US2008064857A1PendingUtilityA1

Methods and Reagents for Diagnosis and Treatment of Diabetes

49
Assignee: METABOLEX INCPriority: Dec 3, 2001Filed: Sep 20, 2007Published: Mar 13, 2008
Est. expiryDec 3, 2021(expired)· nominal 20-yr term from priority
Inventors:Jeffrey D. JohnsonJohn BlumeJohn F. PalmaYun-Ping Zhou
H04W 12/04H04L 63/062H04W 60/00H04W 4/80
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to methods and reagents for diagnosing and treating diabetes.

Claims

exact text as granted — not AI-modified
1 . An isolated antibody that binds to SEQ ID NO:2.  
     
     
         2 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:9.  
     
     
         3 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:10.  
     
     
         4 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:11.  
     
     
         5 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:12.  
     
     
         6 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:13.  
     
     
         7 . The isolated antibody of  claim 1 , wherein the antibody binds to SEQ ID NO:14.  
     
     
         8 . The isolated antibody of  claim 1 , wherein the antibody is monoclonal.  
     
     
         9 . The isolated antibody of  claim 1 , wherein the antibody is polyclonal.  
     
     
         10 . The isolated antibody of  claim 1 , wherein the antibody is bound to a solid substrate.  
     
     
         11 . The isolated antibody of  claim 1 , wherein the antibody is detectably labeled.

Join the waitlist — get patent alerts

Track US2008064857A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.